Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangcheng Li

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Frontiers in Oncology|May 26, 2022
ROBO1 p.E280* Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 SignalTao Zhou, Yaodong Zhang, Yananlan Chen, et al.
Free Radical Biology & Medicine|May 2, 2024
Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathwayYirui Wang, Shuochen Liu, Ming Ni, et al.
Molecular Cancer|February 16, 2024
CircPCNXL2 promotes tumor growth and metastasis by interacting with STRAP to regulate ERK signaling in intrahepatic cholangiocarcinomaShuochen Liu, Yirui Wang, Tianlin Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 11, 2023
Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylationYananlan Chen, Xiao Xu, Yirui Wang, et al.
Drug Delivery|March 9, 2021
Development of cisplatin-loaded hydrogels for trans-portal vein chemoembolization in an orthotopic liver cancer mouse modelXinxiang Yang, Wai-Ho Oscar Yeung, Kel Vin Tan, et al.
International Journal of Biological Sciences|April 14, 2023
NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1Jijun Shan, Wangjie Jiang, Jiang Chang, et al.
NPJ Precision Oncology|April 8, 2025
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatmentShiyun Cui, Hejian Zheng, Yiyang Xu, et al.
Journal for Immunotherapy of Cancer|June 8, 2026
USP1-mediated lipophagy-lipogenesis axis drives cholangiocarcinoma progression and immune evasionYananlan Chen, Xiao Xu, Shenye Shao, et al.
Journal of Hepatology|May 11, 2010
Comparative proteome profile during the early period of small-for-size liver transplantation in rats revealed the protective role of Prdx5Jindao Wu, Qiyun Tang, Jian Shen, et al.
Cell Discovery|July 29, 2024
Structural basis of antagonist selectivity in endothelin receptorsJunyi Hou, Shenhui Liu, Xiaodan Zhang, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Frontiers in Oncology|May 26, 2022
ROBO1 p.E280* Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 SignalTao Zhou, Yaodong Zhang, Yananlan Chen, et al.
Free Radical Biology & Medicine|May 2, 2024
Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathwayYirui Wang, Shuochen Liu, Ming Ni, et al.
Molecular Cancer|February 16, 2024
CircPCNXL2 promotes tumor growth and metastasis by interacting with STRAP to regulate ERK signaling in intrahepatic cholangiocarcinomaShuochen Liu, Yirui Wang, Tianlin Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 11, 2023
Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylationYananlan Chen, Xiao Xu, Yirui Wang, et al.
Drug Delivery|March 9, 2021
Development of cisplatin-loaded hydrogels for trans-portal vein chemoembolization in an orthotopic liver cancer mouse modelXinxiang Yang, Wai-Ho Oscar Yeung, Kel Vin Tan, et al.
International Journal of Biological Sciences|April 14, 2023
NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1Jijun Shan, Wangjie Jiang, Jiang Chang, et al.
NPJ Precision Oncology|April 8, 2025
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatmentShiyun Cui, Hejian Zheng, Yiyang Xu, et al.
Journal for Immunotherapy of Cancer|June 8, 2026
USP1-mediated lipophagy-lipogenesis axis drives cholangiocarcinoma progression and immune evasionYananlan Chen, Xiao Xu, Shenye Shao, et al.
Journal of Hepatology|May 11, 2010
Comparative proteome profile during the early period of small-for-size liver transplantation in rats revealed the protective role of Prdx5Jindao Wu, Qiyun Tang, Jian Shen, et al.
Cell Discovery|July 29, 2024
Structural basis of antagonist selectivity in endothelin receptorsJunyi Hou, Shenhui Liu, Xiaodan Zhang, et al.
Pageof 17